JPMorgan Diversified Return International Eqty ETF vs Eli Lilly And Co — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $73.74, while Eli Lilly And Co trades at $1,173 (market cap $1.02T). The key difference: Eli Lilly And Co pays a 0.6% dividend while JPMorgan Diversified Return International Eqty ETF pays none. Which is the better fit depends on your goals.
| JPIN | LLY | |
|---|---|---|
52-Week High | $76.96 | $1.24K |
52-Week Low | $63.14 | $625.65 |
Market Cap | — | $1.02T |
Sector | — | Health |
Enterprise Value | — | $1.06T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,175.15, down 0.33% on the day, with a bullish technical signal and strong fundamental momentum. Revenue surged to $65.18B in 2025, with net income reaching $20.64B, and the company has beaten earnings estimates for three consecutive quarters. Recent news includes a lawsuit from Novo Nordisk over weight-loss drug advertising, but analyst sentiment remains overwhelmingly positive with a $1,380 consensus price target.
Outlook is supported by robust earnings growth and high profitability margins, but risks include competitive pressures and elevated valuation multiples. The stock's current price is near key resistance at $1,174, with institutional buying activity indicating continued confidence in Lilly's growth trajectory in the pharmaceutical sector.
Trailing returns across standard periods
Latest headlines on both assets
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →